Senores Pharmaceuticals Limited SENORES

Latest filings

• Routine15 28 Sept, 11:31 · BSE
  Senores Pharmaceuticals Limited has informed the Exchange regarding Scrutinizer Report and Voting results of 09th Annual General Meeting
• Routine15 25 Sept, 16:54 · NSE
  Proceedings of Annual General Meeting held on September 25, 2026
• Routine15 24 Sept, 18:00 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
• General25 21 Sept, 12:04 · NSE
  General Updates
• General25 21 Sept, 11:59 · BSE
  Clarification Letter on volume movement in the scrip of the Company
• Routine15 21 Sept, 11:34 · BSE
  The Exchange has sought clarification from Senores Pharmaceuticals Ltd on September 21, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
• Approval73 11 Sept, 13:45 · NSE
  Successful Completion of USFDA Inspection
• Routine15 9 Sept, 17:15 · BSE
  We are submitting herewith the Corrigendum to the Annual Report of the Company for the financial year 2025-26.
• Routine15 4 Sept, 12:35 · BSE
  Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Newspaper Publication
• Routine15 3 Sept, 17:08 · BSE
  Senores Pharmaceuticals Ltd - 544319 - Business Responsibility and Sustainability Reporting (BRSR)

Shown 15 minutes after publication. Real time with Pro.